SCHEMBL21242333

SCHEMBL21242333

Cc1cc(I)c(=O)[nH]c1C(N)=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 2/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
PDPK1 O15530 1/20 0.32
MAP2 P11137 1/20 0.32
MAPT P10636 1/20 0.32
DPYD Q12882 1/20 0.31
PKM P14618 1/20 0.31
DAO P14920 1/20 0.31
DDO Q99489 1/20 0.31
GRIA1 P42261 2/20 0.31
GRIA2 P42262 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21242644 0.82 BRD4 (0.37) HSD17B10KDM4EGAAHPGDGRIN2D
SCHEMBL31639180 0.79 PDPK1 (0.41) HSD17B10KDM4EGAAHPGDGRIN2D
SCHEMBL17362522 0.78 MAP2K1 (0.40) HSD17B10KDM4EGAAHPGDGRIN2D
SCHEMBL17883332 0.74 ALDH1A1 (0.38) PDPK1MAP2MAPTALDH1A1BRD4
SCHEMBL12946182 0.71 HSD17B10 (0.50) HSD17B10KDM4EGAAHPGDGRIN2D
SCHEMBL11865775 0.67 PDPK1 (0.41) PDPK1MAP2
SCHEMBL31502285 0.67 CAPN1 (0.46) PDPK1MAP2MAPTBRD4
SCHEMBL30317842 0.67 SLC9A1 (0.36) PDPK1MAP2BRD4
SCHEMBL2222259 0.66 SIRT3 (0.39) KDM4EGAAALDH1A1BRD4POLB
SCHEMBL5862445 0.65 DPYD (0.39) HSD17B10KDM4EGAAHPGDGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020155842-A1 POLYCYCLIC COMPOUND INHIBITING MNK1 AND MNK2 诺沃斯达药业有限公司 2020-08-06 WO disclosed
EP-3521289-A1 MNK INHIBITORS AND METHODS RELATED THERETO Effector Therapeutics Inc. (US) 2019-08-07 EP disclosed